Trial Profile

A Randomized, Double-blind, Placebo-controlled, Alternating Panel Single Ascending Dose, Sequential Multiple Ascending Dose, and Food Effect Study of FM101 in Healthy Male and Female Volunteers

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 11 Aug 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs FM 101 Future Medicine (Primary)
Indications Diabetic neuropathies; Glaucoma; Non-alcoholic steatohepatitis; Ocular hypertension; Primary biliary cirrhosis
Focus Adverse reactions; First in man; Pharmacokinetics
Sponsors Future Medicine

Most Recent Events

01 Aug 2021 Planned End Date changed from 30 Oct 2019 to 11 Aug 2019.
01 Aug 2021 Status changed to recruiting.
07 Sep 2020 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com